Welcome!

Microsoft Cloud Authors: Liz McMillan, Elizabeth White, Mihai Corbuleac, Pat Romanski, David Bermingham

News Feed Item

China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013

2Q13 New Subscribers Up 33.0% to 18,491

HONG KONG, Nov. 19, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the second quarter and first half of fiscal year 2013, which ended September 30, 2012.

Second Quarter of Fiscal 2013 Highlights

  • Revenues for the second quarter of fiscal 2013 increased by 30.5% to RMB128.5 million ($20.4 million) from RMB98.4 million in the prior year period.
  • New subscriber sign-ups and accumulated subscriber base were 18,491 and 274,705, respectively.
  • Gross profit increased by 32.3% to RMB101.4 million ($16.1 million) from RMB76.7 million in the prior year period.
  • Gross margin was 78.9%, compared to 77.9% in the prior year period.
  • Operating income increased by 24.7% to RMB47.0 million ($7.5 million) from RMB37.7 million in the prior year period, after taking into account the increased management and staff related costs.
  • Interest expense amounted to RMB14.1 million ($2.2 million), which was largely attributable to the convertible note issued to KKR China Healthcare Investment Limited ("KKR"), compared to RMB1.2 million in the prior year period.
  • Net income attributable to shareholders increased by 6.2% to RMB24.7 million ($3.9 million) from RMB23.2 million in the prior year period.
  • Operating cash flow for the quarter amounted to RMB142.5 million ($22.7 million).

First Half of Fiscal 2013 Highlights

  • Revenues for the first half of fiscal 2013 increased by 31.1% to RMB243.8 million ($38.8 million) from RMB185.9 million in the prior year period.
  • New subscriber sign-up reached 34,951 and accumulated subscriber base expanded to 274,705.
  • Gross profit increased by 33.3% to RMB192.3 million ($30.6 million) from RMB144.3 million in the prior year period.
  • Operating income increased by 33.5% to RMB91.4 million ($14.6 million) from RMB68.5 million in the prior year period.
  • Interest expense amounted to RMB24.3 million ($3.9 million), compared to RMB1.7 million in the prior year period.
  • Net income attributable to shareholders amounted to RMB55.8 million ($8.9 million), compared to RMB63.3 million in the prior year period.
  • Operating cash flow for the first half of fiscal 2013 was RMB279.4 million ($44.5 million).

"Coming off of robust growth in our financial performance and yet another record in new subscriber numbers, we concluded the first half of fiscal 2013 with notable achievements and records," stated Ms. Ting Zheng, Chief Executive Officer of China Cord Blood Corporation.  "A high mark of 18,491 in new subscriber numbers, which is our highest increase for any single quarter, reflects our continued commitment to optimize our marketing strategy to deepen penetration and enhance our subscriber base.  Our management team's execution capabilities have also been demonstrated by positive performance in such areas as revenue, operating income and built-up cash flow streams resulting from greater volume of upfront customer payments.  These achievements have not only established a solid foundation for the Company to generate long-term sustainable growth, but also provide a platform for the Company to grasp timely opportunities for geographical expansion."

Ms. Zheng further commented, "We are very pleased to have recently received valuable support from KKR and our major shareholder, Golden Meditech Holdings Limited ("Golden Meditech"), who share CCBC's vision for growing the Company in China and throughout the Asia-Pacific region.  Both KKR and Golden Meditech bring valuable management resources and strategic perspectives that fit the Company's expansion plans.  Under the leadership of Mr. Yuen Kam as our newly appointed Chairman and with his extensive experience in China's healthcare industry, the management team and I believe that the present synergies will help drive the Company towards further operational growth and strategic development."

Summary – The Second Quarter and First Half Ended September 30, 2011 and 2012


Three Months Ended September 30,


Six Months Ended September 30,


2011


2012


2011


2012

(in thousands)

RMB


RMB

US$


RMB


RMB

US$

Revenues

98,433


128,462

20,440


185,891


243,792

38,791

Gross Profit

76,676


101,405

16,135


144,266


192,346

30,605

Operating Income

37,725


47,044

7,485


68,477


91,442

14,550

Net Income Attributable to Shareholders

23,249


24,695

3,929


63,271


55,788

8,878

 

Earnings per Ordinary Shares 
- Basic(1) and Diluted (RMB/US$)

0.31


0.34

0.05


0.85


0.75

0.12











Revenue Breakdown (%)










Processing Fees

74.9%


76.4%



74.5%


75.9%


Storage Fees

25.1%


23.6%



25.5%


24.1%












New Subscribers (persons)

13,899


18,491



26,727


34,951


Total Accumulated Subscribers (persons)

212,557


274,705



212,557


274,705


Summary – Selected Cash Flow Statement Items


Three Months Ended


Six Months Ended


September 30, 2012


September 30, 2012

(in thousands)

RMB

US$


RMB

US$

Net cash provided by operating activities

142,534

22,679


279,406

44,457

Net cash used in investing activities

(5,896)

(938)


(88,424)

(14,069)

Net cash provided by financing activities

41,314

6,574


340,360

54,156

Second Quarter Fiscal 2013 Financial Results

REVENUES.  Revenues increased by 30.5% to RMB128.5 million ($20.4 million) in the second quarter of fiscal 2013 from RMB98.4 million in the prior year period, driven mainly by a significant increase in new subscriber sign-ups during the quarter and expansion in our accumulated subscriber base.  

Revenues generated from storage fees increased to RMB30.3 million ($4.8 million), up 22.7% from RMB24.7 million in the prior year period.  In light of the significant increase in new subscribers, revenue from storage fees accounted for a lesser of 23.6% of total revenues, compared to 25.1% in the prior year period.  

Revenues generated from processing fees were RMB98.2 million ($15.6 million), up 33.2% from RMB73.7 million in the prior year period, reflecting 18,491 new subscriber sign-ups this quarter, a 33.0% annual increase and a 12.3% sequential increase in new subscriber sign-ups.  Revenues generated from processing fees accounted for 76.4% of total revenues, compared to 74.9% in the prior year period.

GROSS PROFIT.  Gross profit for the second quarter of fiscal 2013 increased by 32.3% to RMB101.4 million ($16.1 million) from RMB76.7 million in the prior year period, benefiting from economies of scale.  Gross margin was 78.9%, compared to 77.9% in the prior year period.

OPERATING INCOME.  Operating income for the second quarter increased at a slower pace to RMB47.0 million ($7.5 million) compared to RMB37.7 million in the prior year period.  Operating margin was slightly down to 36.6%, compared to 38.3% in the prior year period, as a result of an increase in management and staff related costs, as well as an increase in depreciation expenses as we begin to depreciate part of the new facility in Guangdong.  Depreciation and amortization expenses for the second quarter were RMB8.3 million ($1.3 million), compared to RMB7.1 million in the prior year period.  

  • Research and Development Expenses.  Research and development expenses remained stable at RMB1.9 million ($0.3 million) compared to RMB1.9 million in the prior year period, a reflection of the Company's continuous efforts to enhance operations through technology advancement.
  • Sales and Marketing Expenses.  Sales and marketing expenses, increased by 51.0% to RMB23.5 million ($3.7 million) from RMB15.6 million in the prior year period.  These expenses indicated our continuous reach-out to deeply penetrate into the Beijing market, further marketing campaigns to outreach to potential subscribers in the Guangdong market, as well as costs for the building up of development for the Zhejiang market.  Sales and marketing expenses represented 18.3% of revenues in the second quarter of fiscal 2013, up from 15.8% in the prior year period and 16.7% in the first quarter of fiscal 2013.
  • General and Administrative Expenses.  General and administrative expenses were RMB29.0 million ($4.6 million), compared to RMB21.4 million in the prior year period and RMB25.1 million in the first quarter of fiscal 2013, mainly due to an increase in management and staff related costs of RMB4.6 million ($0.7 million).  As a percentage of revenue, it increased to 22.6% compared to 21.8% in the prior year period and compared to 21.7% in the first quarter of fiscal 2013.  

OTHER INCOME AND EXPENSES

  • Interest Expense.  Interest expense increased to RMB14.1 million ($2.2 million) from RMB1.2 million in the prior year period.  The increase was largely attributable to the issuance of a convertible note to KKR in April 2012.  In the second quarter of fiscal 2013, interest expense related to the convertible note annual coupon payment amounted to RMB7.3 million ($1.2 million) and the amortization of other related costs amounted to RMB6.0 million ($1.0 million).

NET INCOME ATTRIBUTABLE TO SHAREHOLDERS.  Net income attributable to shareholders for the second quarter of fiscal 2013 increased by 6.2% to RMB24.7 million ($3.9 million) from RMB23.2 million in the prior year period.  Net margin for the second quarter of fiscal 2013 was 19.2%. 

EARNINGS PER SHARE.  The terms of the convertible note issued to KKR provides KKR with the ability to participate in any Excess Cash Dividend(2).  Therefore, the calculation of basic EPS has taken into consideration KKR's participating right effect of RMB0.01.  Basic and diluted earnings per ordinary share for the second quarter of fiscal 2013 were RMB0.34 ($0.05)

LIQUIDITY.  As of September 30, 2012, the Company had cash and cash equivalents of RMB1,324.5 million ($210.7 million) compared to RMB794.3 million as of March 31, 2012.  The Company had total debt of RMB472.6 million ($75.2 million) as of September 30, 2012.  Operating cash flow for the quarter amounted to RMB142.5 million ($22.7 million).

First Half Fiscal 2013 Financial Results

For the first half of fiscal year 2013, total revenues increased by 31.1% to RMB243.8 million ($38.8 million) from RMB185.9 million in the prior year period.  The increase was largely attributable to the significant increase in new subscribers and the expansion of the Company's accumulated subscriber base to 274,705 subscribers.  Processing fees and storage fees grew by 33.6% and 24.0%, respectively.  Gross profit increased by 33.3% to RMB192.3 million ($30.6 million) from RMB144.3 million in the prior year period.  Operating income increased by 33.5% to RMB91.4 million ($14.6 million) from RMB68.5 million in the prior year period. Net income attributable to shareholders amounted to RMB55.8 million ($8.9 million).  Basic and diluted earnings per share attributable to ordinary shares were RMB0.75 ($0.12).  Net cash provided by operating activities in the first half of fiscal 2013 was RMB279.4 million ($44.5 million).

Ms. Zheng concluded, "Even though we recorded impressive performance in our operating markets, we are continuing our efforts to widen market coverage and deepen penetration to capture more of the large regional market potential presented in Beijing, Guangdong and Zhejiang.  We have seen encouraging market responses during this start-up phase of our Zhejiang operation while actively searching for an optimal location to build our facility in the province.  For the Guangdong market, our new facility is well under way in construction to increase capacity in this promising region.  CCBC recently completed a transaction with Cordlife Group Limited ("Cordlife"), which has resulted in the Company now wholly owning our Guangdong subsidiary, thereby allowing the Company to fully benefit from the strong sales and future growth potential of this affluent market.  The strengthening of our long-standing strategic alliance with Cordlife opens additional avenues for us to develop Pan-Asian markets.  Since April 2012, we have bought back approximately $20.3 million worth of shares.  With the resources and talents on hand, we aim to enhance shareholder value by expanding our China and Pan-Asia footprint while continuing to explore opportunities to reward our shareholders for their ongoing support." 

(1) The terms of the convertible note issued to KKR provides KKR with the ability to participate in any excess cash dividend.  Therefore, the calculation of basic EPS has taken into consideration KKR's participating right effect of RMB0.01 and RMB0.03 for the three months and six months ended September 30, 2012, respectively.

(2) "Excess Cash Dividend" means any cash dividend to holders of shares that, together with all other cash dividends previously paid to holders of shares in the same financial year, exceeds, on a per share basis, an amount equal to the interest that has accrued and shall accrue at 7% in such financial year divided by the number of shares into which the note is convertible at the conversion price then in effect on the relevant record date.

Conference Call

The Company will host a conference call at 8:00 a.m. ET on Tuesday, November 20, 2012 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session.  Interested parties may access the audio webcast through the Company's IR website at http://ir.chinacordbloodcorp.com.  A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above.  Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 50728737.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services.  For more information, please visit our website at http://www.chinacordbloodcorp.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or the Company's future financial performance. The Company has attempted to identify forward-looking statements by terminology including "anticipates", "believes", "expects", "can", "continue", "could", "estimates", "intends", "may", "plans", "potential", "predict", "should" or "will" or the negative of these terms or other comparable terminology. These statements are only predictions, uncertainties and other factors may cause the Company's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. The information in this press release is not intended to project future performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company does not guarantee future results, levels of activity, performance or achievements. The Company expectations are as of the date this press release is issued, and the Company does not intend to update any of the forward-looking statements after the date this press release is issued to confirm these statements to actual results, unless required by law.

The forward-looking statements included in this press release are subject to risks, uncertainties and assumptions about the Company's businesses and business environments. These statements reflect the Company's current views with respect to future events and are not a guarantee of future performance. Actual results of the Company's operations may differ materially from information contained in the forward-looking statements as a result of risk factors some of which include, among other things: continued compliance with government regulations regarding cord blood banking in the People's Republic of China, or PRC; changing legislation or regulatory environments in the PRC; the acceptance by subscribers of the Company's different pricing and payment options and reaction to the introduction of the Company's premium-quality pricing strategy; demographic trends in the regions of the PRC in which the Company is the exclusive licensed cord blood banking operator; labor and personnel relations; credit risks affecting the Company's revenue and profitability; changes in the healthcare industry, including those which may result in the use of stem cell therapies becoming redundant or obsolete; the Company's ability to effectively manage its growth, including implementing effective controls and procedures and attracting and retaining key management and personnel; changing interpretations of generally accepted accounting principles; the availability of capital resources, including in the form of capital markets financing opportunities, in light of industry developments affecting issuers that have pursued a "reverse merger" with an operating company based in China, as well as general economic conditions; and other relevant risks detailed in the Company's filings with the Securities and Exchange Commission.

This announcement contains translations of certain Renminbi amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from Renminbi to U.S. dollars as of and for the periods ending September 30, 2012 were made at the noon buying rate of RMB6.2848 to $1.00 on September 28, 2012 in the City of New York for cable transfers in Renminbi per U.S. dollar as certified for customs purposes by the Federal Reserve Bank of New York. China Cord Blood Corporation makes no representation that the Renminbi or U.S. dollar amounts referred to in this press release could have been or could be converted into U.S. dollars or Renminbi, at any particular rate or at all.

For more information, please contact:

China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: [email protected]  

ICR, Inc.
Mr. Rob Koepp
Tel: (+86) 10-6583-7516
U.S. Tel: (646) 405-5185

EXHIBIT 1

 

 

CHINA CORD BLOOD CORPORATION

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

As of March 31 and September 30, 2012

 


March 31,


September 30,


2012


2012


RMB


RMB


US$


(in thousands except share data)







ASSETS






Current assets






Cash and cash equivalents

794,311


1,324,507


210,748

Accounts receivable, less allowance for doubtful accounts






  (March 31, 2012: RMB13,916; September 30, 2012: RMB14,841)

79,012


78,627


12,511

Inventories

6,666


5,074


807

Prepaid expenses and other receivables

11,561


15,055


2,395

Trading securities

354


-


-

Deferred offering costs

-


2,852


454

Deferred tax assets

5,268


5,715


909

Total current assets

897,172


1,431,830


227,824

Property, plant and equipment, net

267,862


345,279


54,939

Non-current prepayments

2,863


3,144


500

Non-current accounts receivable, less allowance for doubtful accounts






(March 31, 2012: RMB38,628; September 30, 2012: RMB42,744)

254,236


246,086


39,156

Inventories

34,651


37,773


6,010

Intangible assets, net

129,791


127,481


20,284

Available-for-sale equity securities

98,199


78,332


12,464

Other investment

134,363


134,363


21,379

Deferred offering costs

-


10,183


1,620

Deferred tax assets

5,013


5,879


935

Total assets

1,824,150


2,420,350


385,111







LIABILITIES






Current liabilities






Bank loan

45,000


50,000


7,956

Accounts payable

6,343


14,234


2,265

Accrued expenses and other payables

33,351


62,555


9,953

Deferred revenue

106,110


151,496


24,105

Amounts due to related party

360


720


115

Income tax payable

5,943


5,809


924

Total current liabilities

197,107


284,814


45,318

Convertible notes

-


422,569


67,237

Non-current deferred revenue

306,534


406,359


64,657

Other non-current liabilities

60,420


81,455


12,961

Deferred tax liabilities

24,462


23,306


3,708

Total liabilities

588,523


1,218,503


193,881







EQUITY






Shareholders' equity






Ordinary shares






-   US$0.0001 par value, 250,000,000 shares authorized, 73,140,147






shares issued and outstanding as of March 31, 2012 and






73,140,147 shares issued and 69,064,092 shares outstanding






as of September 30, 2012

50


50


8

Additional paid-in capital

865,654


865,654


137,737

Treasury stock

-


(72,675)


(11,564)

Accumulated other comprehensive income

26,057


3,705


589

Retained earnings

310,973


366,761


58,358

Total shareholders' equity

1,202,734


1,163,495


185,128

Non-controlling interests

32,893


38,352


6,102

Total equity

1,235,627


1,201,847


191,230

Total liabilities and equity

1,824,150


2,420,350


385,111







 

EXHIBIT 2

 

 

CHINA CORD BLOOD CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the Three Months and Six Months ended September 30, 2011 and 2012

 


Three months ended September 30,

Six months ended September 30,


2011


2012


2011


2012


RMB


RMB


US$


RMB


RMB


US$


(in thousands except share data)













Revenues

98,433


128,462


20,440


185,891


243,792


38,791

Direct costs

(21,757)


(27,057) 


(4,305) 


(41,625)


(51,446) 


(8,186) 

Gross profit

76,676


101,405


16,135


144,266


192,346


30,605

Operating expenses












Research and development

(1,932)


(1,860)


(296)


(3,709)


(4,123)


(656)

Sales and marketing

(15,575)


(23,517)


(3,742)


(28,181)


(42,737)


(6,800)

General and administrative

(21,444)


(28,984) 


(4,612) 


(43,899)


(54,044) 


(8,599) 

Total operating expenses

(38,951)


(54,361) 


(8,650) 


(75,789)


(100,904) 


(16,055) 

Operating income

37,725


47,044 


7,485 


68,477


91,442 


14,550 

Other (expense)/income , net












Interest income

3,312


3,859


614


6,451


7,188


1,144

Interest expense

(1,190)


(14,089)


(2,242)


(1,650)


(24,265)


(3,861)

Exchange (loss)/gain

(4,956)


41


7


(4,860)


51


8

Dividend income

-


-


-


7,217


2,420


385

Others

111


(1,002) 


(160) 


325


(766) 


(121) 

Total other (expense)/income, net

(2,723)


(11,191) 


(1,781) 


7,483


(15,372) 


(2,445) 

Income before income tax

35,002


35,853


5,704


75,960


76,070


12,105

Income tax expense

(9,093)


(8,466) 


(1,347) 


(7,310)


(14,801) 


(2,355) 

Net income

25,909


27,387


4,357


68,650


61,269


9,750

Income attributable to non-controlling interests

(2,660)


(2,692) 


(428) 


(5,379)


(5,481) 


(872) 

Net income attributable to shareholders

23,249


24,695 


3,929 


63,271


55,788 


8,878 













Net income per share:












Attributable to ordinary shares












-   Basic

0.31


0.34


0.05


0.85


0.75


0.12

-   Diluted

0.31


0.34 


0.05 


0.85


0.75 


0.12 

Other comprehensive income












-   Net effect of foreign currency translation, net of nil tax

122


(1,007)


(160)


(689)


(2,424)


(386)

-   Net unrealized (loss)/gain in available-for-sale equity securities, net of nil tax

(5,976) 


2,624 


418 


(11,508) 


(19,950) 


(3,174) 

Comprehensive income

20,055 


29,004 


4,615 


56,453 


38,895 


6,190 













Comprehensive income attributable to non-controlling interests

(2,680)


(2,672)


(425)


(5,605)


(5,459)


(869) 

Comprehensive income attributable to shareholders

17,375 


26,332 


4,190 


50,848 


33,436 


5,321 

 

SOURCE China Cord Blood Corporation

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
In his session at 18th Cloud Expo, Bruce Swann, Senior Product Marketing Manager at Adobe, will discuss how the Adobe Marketing Cloud can help marketers embrace opportunities for personalized, relevant and real-time customer engagement across offline (direct mail, point of sale, call center) and digital (email, website, SMS, mobile apps, social networks, connected objects). Bruce Swann has more than 15 years of experience working with digital marketing disciplines like web analytics, social med...
SYS-CON Events announced today that Enzu, a leading provider of cloud hosting solutions, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive advantage. By offering a suite of proven hosting and management services, Enzu wants companies to foc...
Customer experience has become a competitive differentiator for companies, and it’s imperative that brands seamlessly connect the customer journey across all platforms. With the continued explosion of IoT, join us for a look at how to build a winning digital foundation in the connected era – today and in the future. In his session at @ThingsExpo, Chris Nguyen, Group Product Marketing Manager at Adobe, will discuss how to successfully leverage mobile, rapidly deploy content, capture real-time d...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, wh...
IoT generates lots of temporal data. But how do you unlock its value? How do you coordinate the diverse moving parts that must come together when developing your IoT product? What are the key challenges addressed by Data as a Service? How does cloud computing underlie and connect the notions of Digital and DevOps What is the impact of the API economy? What is the business imperative for Cognitive Computing? Get all these questions and hundreds more like them answered at the 18th Cloud Expo...
As cloud and storage projections continue to rise, the number of organizations moving to the cloud is escalating and it is clear cloud storage is here to stay. However, is it secure? Data is the lifeblood for government entities, countries, cloud service providers and enterprises alike and losing or exposing that data can have disastrous results. There are new concepts for data storage on the horizon that will deliver secure solutions for storing and moving sensitive data around the world. ...
What a difference a year makes. Organizations aren’t just talking about IoT possibilities, it is now baked into their core business strategy. With IoT, billions of devices generating data from different companies on different networks around the globe need to interact. From efficiency to better customer insights to completely new business models, IoT will turn traditional business models upside down. In the new customer-centric age, the key to success is delivering critical services and apps wit...
The IoT is changing the way enterprises conduct business. In his session at @ThingsExpo, Eric Hoffman, Vice President at EastBanc Technologies, discuss how businesses can gain an edge over competitors by empowering consumers to take control through IoT. We'll cite examples such as a Washington, D.C.-based sports club that leveraged IoT and the cloud to develop a comprehensive booking system. He'll also highlight how IoT can revitalize and restore outdated business models, making them profitable...
The essence of data analysis involves setting up data pipelines that consist of several operations that are chained together – starting from data collection, data quality checks, data integration, data analysis and data visualization (including the setting up of interaction paths in that visualization). In our opinion, the challenges stem from the technology diversity at each stage of the data pipeline as well as the lack of process around the analysis.
Designing IoT applications is complex, but deploying them in a scalable fashion is even more complex. A scalable, API first IaaS cloud is a good start, but in order to understand the various components specific to deploying IoT applications, one needs to understand the architecture of these applications and figure out how to scale these components independently. In his session at @ThingsExpo, Nara Rajagopalan is CEO of Accelerite, will discuss the fundamental architecture of IoT applications, ...
SYS-CON Events announced today that ContentMX, the marketing technology and services company with a singular mission to increase engagement and drive more conversations for enterprise, channel and SMB technology marketers, has been named “Sponsor & Exhibitor Lounge Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York City, New York. “CloudExpo is a great opportunity to start a conversation with new prospects, but what happens after the...
SYS-CON Events announced today that MangoApps will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. MangoApps provides modern company intranets and team collaboration software, allowing workers to stay connected and productive from anywhere in the world and from any device. For more information, please visit https://www.mangoapps.com/.
SYS-CON Events announced today that 24Notion has been named “Bronze Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. 24Notion is full-service global creative digital marketing, technology and lifestyle agency that combines strategic ideas with customized tactical execution. With a broad understand of the art of traditional marketing, new media, communications and social influence, 24Notion uniquely understands how to con...
WebRTC is bringing significant change to the communications landscape that will bridge the worlds of web and telephony, making the Internet the new standard for communications. Cloud9 took the road less traveled and used WebRTC to create a downloadable enterprise-grade communications platform that is changing the communication dynamic in the financial sector. In his session at @ThingsExpo, Leo Papadopoulos, CTO of Cloud9, will discuss the importance of WebRTC and how it enables companies to fo...
SYS-CON Events announced today TechTarget has been named “Media Sponsor” of SYS-CON's 18th International Cloud Expo, which will take place on June 7–9, 2016, at the Javits Center in New York City, NY, and the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. TechTarget is the Web’s leading destination for serious technology buyers researching and making enterprise technology decisions. Its extensive global networ...
Korean Broadcasting System (KBS) will feature the upcoming 18th Cloud Expo | @ThingsExpo in a New York news documentary about the "New IT for the Future." The documentary will cover how big companies are transmitting or adopting the new IT for the future and will be filmed on the expo floor between June 7-June 9, 2016, at the Javits Center in New York City, New York. KBS has long been a leader in the development of the broadcasting culture of Korea. As the key public service broadcaster of Korea...
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York and Silicon Valley. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty ...
The 19th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit y...
There are several IoTs: the Industrial Internet, Consumer Wearables, Wearables and Healthcare, Supply Chains, and the movement toward Smart Grids, Cities, Regions, and Nations. There are competing communications standards every step of the way, a bewildering array of sensors and devices, and an entire world of competing data analytics platforms. To some this appears to be chaos. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will discuss the vast to...
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with the 19th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world and ThingsExpo New York Call for Papers is now open.